Detalles de la búsqueda
1.
Letter by Rozenbaum et al Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy".
Circulation
; 142(15): e210-e211, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33044864
2.
Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx).
Cardiol Ther
; 13(2): 369-378, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615093
3.
Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States.
Am J Cardiovasc Drugs
; 23(2): 197-206, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36780092
4.
Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort.
J Manag Care Spec Pharm
; 28(7): 766-777, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35737856
5.
Baseline Characteristics and Secondary Medication Adherence Patterns Among Patients Receiving Tafamidis Prescriptions: A Retrospective Analysis Using a National Specialty Pharmacy Dispensing Database.
Patient Prefer Adherence
; 16: 1115-1129, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35517043
6.
Effect of methylphenidate formulation on treatment patterns and use of emergency room services.
Am J Health Syst Pharm
; 63(4): 317-22, 2006 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16452517
7.
Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.
Ambul Pediatr
; 6(1): 45-53, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16443183
8.
Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis.
Ann Gen Psychiatry
; 5: 5, 2006 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-16606463
9.
Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
Arch Pediatr Adolesc Med
; 159(6): 572-8, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15939858
10.
Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.
J Natl Med Assoc
; 97(10 Suppl): 11S-16S, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16350601
11.
Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study.
Adv Ther
; 22(5): 498-512, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16418159
12.
Productivity and medical costs of diabetes in a large employer population.
Diabetes Care
; 25(1): 23-9, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11772896
13.
Cost-effectiveness analysis of treatments for vertebral compression fractures.
Appl Health Econ Health Policy
; 10(4): 273-84, 2012 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22591065
14.
Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?
Am J Geriatr Pharmacother
; 8(3): 201-14, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20624610
15.
Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.
Vaccine
; 27(36): 4930-7, 2009 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-19555715
Resultados
1 -
15
de 15
1
Próxima >
>>